Multiple system atrophy (MSA)
Would you like to receive a message when there is new research about Multiple System Atrophy (MSA)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you'll see one sentence explaining what was studied — and you'll receive a message as soon as there is new research about Multiple System Atrophy (MSA). View what Premium costs.
Publications and studies (1558)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Research progress of chronic fatigue in neurodegenerative diseases. (2025/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Mechanisms of the Effects of Polyphenols on Diabetic Nephropathy. (2025/09/10) ♡
- [Clinical and genetic analysis of six children with RARS2-related pontocerebellar hypoplasia]. (2025/09/10) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Trends in Invasive Interventions and Risk Factors for Early Critical Events in Multiple System Atrophy. (2025/09/06) ♡
- Estimated Brain Age in Healthy Aging and Across Multiple Neurological Disorders. (2025/09/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Neuroprotective role of high dose Vitamin D supplementation in multiple sclerosis: Sub-analysis of the EVIDIMS trial. (2025/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Alpha-synuclein fibril structures cluster into distinct classes. (2025/08/19) ♡
- Altered gut microbial networks and metabolic pathways in multiple system atrophy: a comparative 16S rRNA study. (2025/08/13) ♡
- Bu-zhong-yi-qi decoction regulates JNK/c-JUN signaling pathway to improve skeletal muscle atrophy caused by cancer cachexia. (2025/07/24) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Does Vitamin D Supplementation Slow Brain Volume Loss in Multiple Sclerosis? A 4-Year Observational Study. (2025/07/09) ♡
- NeuroMoE: A Transformer-Based Mixture-of-Experts Framework for Multi-Modal Neurological Disorder Classification. (2025/07/01) ♡
- Physiological and morphological impact of physical activity and nutritional interventions to offset disuse-induced skeletal muscle atrophy. (2025/06/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Neurology of Androgens and Androgenic Supplements. (2025/06/03) ♡
- Morphometry of choroid plexus epithelial cells in neurodegenerative diseases. (2025/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Examination of the autonomic nervous system at the bedside. (2025/06/01) ♡
- Blood-brain barrier dysfunction in multiple system atrophy: A human postmortem study. (2025/06/01) ♡
- Decision-making trends in therapeutic interventions for multiple system atrophy: a 24-year retrospective study. (2025/06/01) ♡
- Potential scalp acupuncture and brain stimulation targets for common neurological disorders: evidence from neuroimaging studies. (2025/05/07) ♡
- Novel Digital Anomalies, Hippocampal Atrophy, and Mutations Expand the Genotypic and Phenotypic Spectra of CNKSR2 in the Houge Type of X-Linked Syndromic Intellectual Development Disorder (MRXSHG). (2025/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Rehabilitation of Women with Neurodegenerative Diseases. (2025/05/01) ♡
- Decreased urinary excretion of norepinephrine and dopamine in autonomic synucleinopathies. (2025/04/01) ♡
- Utility of Cerebrospinal Fluid Transferrin Receptor per Ferritin Ratio in Progressive Supranuclear Palsy. (2025/04/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Neurohistopathological findings of the brain parenchyma after long-term deep brain stimulation: Case series and systematic literature review. (2025/04/01) ♡
- Recommendations for essential medicines for multiple sclerosis in low-resource settings. (2025/04/01) ♡
- Ursolic acid derivatives improved clinical signs of experimental autoimmune encephalomyelitis by modulating central nervous system inflammation. (2025/04/01) ♡
- Frequency of FGF14 intronic GAA repeat expansion in patients with multiple system atrophy and undiagnosed ataxia in the Japanese population. (2025/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cognitive impairment in Parkinson's disease and other parkinsonian syndromes. (2025/03/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Microglial suppression by myeloperoxidase inhibitor does not delay neurodegeneration in a mouse model of progressive multiple sclerosis. (2025/03/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Clinical Correlates of Efficacy of Pyridostigmine in the Treatment of Orthostatic Hypotension. (2025/03/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's disease (PADOVA): Rationale, design, and baseline data. (2025/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. MicroRNA frontiers: Illuminating early detection paths in multiple sclerosis. (2025/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Cortical Ribboning as a Key MRI Finding in Wernicke's Encephalopathy With Altered Mental Status. (2025/02/19) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Behavioral disorders in Parkinson disease: current view. (2025/02/01) ♡
- Dopamine transporter availability based on white matter hyperintensity during early to mid-stage Parkinson's disease and multiple system atrophy: a case control study. (2025/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. From onset to advancement: the temporal spectrum of α-synuclein in synucleinopathies. (2025/02/01) ♡
- Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. AGA Clinical Practice Update on Screening and Surveillance in Individuals at Increased Risk for Gastric Cancer in the United States: Expert Review. (2025/02/01) ♡
- Iron deposition is associated with motor and non-motor network breakdown in parkinsonism. (2025/01/20) ♡
- Combined quantitative analysis of the nigro-striata system in multiple system atrophy and Parkinson's disease. (2025/01/15) ♡
- Inhibition of Phosphorylated Alpha-Synuclein Aggregation by Synthetic Protein Mimetics and Foldamers. (2025/01/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Effect of long-term transcutaneous auricular vagus nerve stimulation in multiple system atrophy-cerebellar subtype: a case report. (2025/01/15) ♡
- Egyptian Novel Goose Parvovirus in Immune Organs of Naturally Infected Ducks: Next-Generation Sequencing, Immunohistochemical Signals, and Comparative Analysis of Pathological Changes Using Multiple Correspondence and Hierarchical Clustering Approach. (2025/01/13) ♡
- Hyperintense lesions of the middle cerebellar peduncle and beyond: a pictorial essay. (2025/01/10) ♡
- Comprehensive analysis of adverse events associated with onasemnogene abeparvovec (Zolgensma) in spinal muscular atrophy patients: insights from FAERS database. (2025/01/07) ♡
- Thalamic volume differentiates multiple sclerosis from neuromyelitis optica spectrum disorder: MRI-based retrospective study. (2025/01/03) ♡
- Chronic Musculoskeletal Pain and Risk of Incident Parkinson's Disease: A 13-Year Longitudinal Study. (2025/01/01) ♡
- Cryo-EM structure of a novel α-synuclein filament subtype from multiple system atrophy. (2025/01/01) ♡
- Increased Survival in Contemporary Parkinson's Disease: A 47-Year Autopsy Study. (2025/01/01) ♡
- Caregiver perspectives enable accurate diagnosis of neurodegenerative disease. (2025/01/01) ♡
- New prospects for (89)Zr-immuno-PET in brain applications - Alpha-synucleinopathies. (2025/01/01) ♡
- Gray Matter Reserve Modulates the Association between Glymphatic System Function and Cognition in Patients with Type 2 Diabetes Mellitus. (2025/01/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.